🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 23 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/04/2007 | 26,58 | 26,69 | 26,16 | 26,58 | +1,14% | 1,97% | 243.229 |
| 18/04/2007 | 26,61 | 26,76 | 26,20 | 26,28 | -2,09% | 2,11% | 212.504 |
| 17/04/2007 | 26,54 | 26,91 | 26,46 | 26,84 | +0,70% | 1,69% | 114.240 |
| 16/04/2007 | 26,24 | 26,76 | 26,20 | 26,65 | +1,71% | 2,14% | 290.116 |
| 13/04/2007 | 26,61 | 26,76 | 26,09 | 26,20 | -1,96% | 2,53% | 300.589 |
| 12/04/2007 | 26,84 | 27,06 | 26,20 | 26,72 | -0,14% | 3,21% | 274.300 |
| 11/04/2007 | 27,70 | 27,89 | 26,69 | 26,76 | -4,16% | 4,32% | 210.527 |
| 10/04/2007 | 27,59 | 28,07 | 27,59 | 27,92 | +1,22% | 1,76% | 187.204 |
| 09/04/2007 | 27,70 | 27,74 | 26,84 | 27,59 | -0,94% | 3,24% | 232.862 |
| 05/04/2007 | 28,15 | 28,22 | 27,74 | 27,85 | -1,06% | 1,73% | 257.896 |
| 04/04/2007 | 28,18 | 28,63 | 27,89 | 28,15 | -0,53% | 2,66% | 362.946 |
| 03/04/2007 | 28,82 | 30,13 | 27,85 | 28,30 | -24,32% | 7,92% | 791.374 |
| 02/04/2007 | 37,92 | 38,55 | 37,24 | 37,39 | -0,89% | 3,45% | 714.858 |
| 30/03/2007 | 37,50 | 39,30 | 37,39 | 37,73 | +0,90% | 5,09% | 1.665.784 |
| 29/03/2007 | 38,59 | 38,89 | 33,16 | 37,39 | -2,44% | 14,84% | 1.172.541 |
| 28/03/2007 | 39,30 | 39,34 | 38,33 | 38,33 | -2,57% | 2,57% | 687.179 |
| 27/03/2007 | 39,45 | 39,71 | 39,04 | 39,34 | -0,10% | 1,71% | 463.000 |
| 26/03/2007 | 39,83 | 40,61 | 39,30 | 39,38 | +0,10% | 3,29% | 1.992.021 |
| 23/03/2007 | 40,39 | 41,32 | 39,23 | 39,34 | -0,85% | 5,19% | 577.454 |
| 22/03/2007 | 42,48 | 42,86 | 39,53 | 39,68 | -1,30% | 7,84% | 2.792.479 |
| 21/03/2007 | 39,30 | 40,39 | 39,23 | 40,20 | +1,99% | 2,95% | 343.363 |
| 20/03/2007 | 38,03 | 39,68 | 37,65 | 39,41 | +2,73% | 5,31% | 301.444 |
| 19/03/2007 | 37,65 | 39,49 | 37,65 | 38,37 | +1,99% | 4,87% | 489.342 |
| 16/03/2007 | 40,87 | 40,91 | 37,32 | 37,62 | -7,97% | 8,79% | 923.328 |
| 15/03/2007 | 40,39 | 42,30 | 40,24 | 40,87 | +1,87% | 5,10% | 266.445 |
| 14/03/2007 | 40,50 | 40,50 | 38,96 | 40,12 | -0,19% | 3,79% | 150.468 |
| 13/03/2007 | 40,91 | 41,14 | 39,71 | 40,20 | -1,74% | 3,48% | 179.509 |
| 12/03/2007 | 41,06 | 41,32 | 40,76 | 40,91 | +0,09% | 1,37% | 195.005 |
| 09/03/2007 | 41,21 | 41,55 | 40,46 | 40,87 | -0,73% | 2,63% | 107.054 |
| 08/03/2007 | 41,21 | 41,55 | 41,06 | 41,17 | +0,64% | 1,18% | 111.676 |